From pills to new uses, here's what Eli Lilly's top scientist sees as the future of weight loss drugs - Eli Lilly aims to invest in 'big problems hiding in plain sight' using obesity windfall - Eli Lilly wants to use its weight loss drug windfall to fight Alzheimer's and hearing loss - Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected - Eli Lilly beats on earnings even as weight loss, diabetes drug sales fall short - Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024 - Stocks making the biggest moves premarket: Ford, Eli Lilly, Honeywell, Arm Holdings and more - Eli Lilly has its mojo back ahead of a pivotal year for the obesity drug giant - Eli Lilly expects to beat profit forecasts on obesity drug demand - Eli Lilly must put to rest doubts about whether Zepbound's growth can live up to the hype